DYRK1A inhibition results in MYC and ERK activation rendering KMT2A-R acute lymphoblastic leukemia cells sensitive to BCL2 inhibition.
Ayyadevara VSSA, Wertheim G, Gaur S, Chukinas JA, Loftus JP, Lee SJ, Kumar A, Swaminathan S, Bhansali RS, Childers W, Geng H, Milne TA, Hua X, Bernt KM, Besson T, Shi J, Crispino JD, Carroll M, Tasian SK, Hurtz C.
Ayyadevara VSSA, et al. Among authors: besson t.
Leukemia. 2025 May;39(5):1078-1089. doi: 10.1038/s41375-025-02575-w. Epub 2025 Mar 27.
Leukemia. 2025.
PMID: 40148558
Free PMC article.